All In Biotech

Drug Trial Radar · NCT00002095

A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus

Last checked: Nov 20, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

700

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy of oral ganciclovir in preventing progression to cytomegalovirus (CMV) disease (e.g., CMV retinitis, gastrointestinal CMV disease) in CMV-infected people with HIV infection and CD4 lymphocyte counts \<= 100 cells/mm3. To evaluate the efficacy of this drug in reducing morbidity associated with coinfection by both CMV and HIV.

Conditions

  • Cytomegalovirus Infections
  • HIV Infections

Interventions

  • GanciclovirDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • East Bay AIDS Ctr

    Berkeley, California

  • Kraus - Beer Med Group

    Los Angeles, California

  • UCSD

    San Diego, California

  • Davies Med Ctr / c/o HIV Institute

    San Francisco, California

  • Mount Zion Med Ctr

    San Francisco, California

  • San Francisco Veterans Administration Med Ctr

    San Francisco, California

  • Harbor - UCLA Med Ctr

    Torrance, California

  • Georgetown Univ Med Ctr

    Washington D.C., District of Columbia

  • Community Research Initiative

    Coral Gables, Florida

  • AIDS Research Consortium of Atlanta

    Atlanta, Georgia

  • Rush Presbyterian - Saint Luke's Med Ctr / Rush Med Coll

    Chicago, Illinois

  • Beth Israel Hosp

    Boston, Massachusetts

  • Kaplan Cancer Ctr / New York Univ Med Ctr

    New York, New York

  • St Lukes - Roosevelt Hosp Ctr

    New York, New York

  • Cornell Univ Med College / New York Hosp

    New York, New York

  • Buckley Braffman Stern Med Associates

    Philadelphia, Pennsylvania

  • Univ of Pittsburgh / Graduate School of Public Health

    Pittsburgh, Pennsylvania

  • Oak Lawn Physicians Group

    Dallas, Texas

  • Infectious Diseases Association of Houston

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.